Aimmune Therapeutics has shared its positive findings from the Phase 3 POSEIDON study of Palforzia.  

Following an independent review of hospital food in 2020, the NHS has published new national standards for healthcare food and drink that all NHS organisations will be legally required to meet as part of their NHS standard contracts.  The new

We are delighted to welcome Professor John Warner OBE as our Clinical and Scientific Ambassador.

Following the publication of the Guideline for the diagnosis and management of Pollen Food/Oral Allergy Syndrome, BSACI will be hosting a webinar on Thursday 13 October 5-6pm. Sarah Baker, Anaphylaxis UK’s Head of Health Policy and Developments, will be speaking

The British Society for Allergy and Clinical Immunology (BSACI) has developed new guidelines for healthcare professionals who are not trained in allergy or immunology, but who wish to develop a penicillin allergy de-labelling service for their patients. An estimated 2.7

A comprehensive survey of children’s allergy services in the UK has found that the number of clinics and appointments have increased but that services vary too widely across the country.  Researchers contacted UK hospitals to find out what allergy services

The British Society for Allergy and Clinical Immunology (BSACI) has announced the publication of the BSACI Guideline for the diagnosis and management of Pollen Food Syndrome/Oral Allergy Syndrome. Pollen Food Syndrome (PFS), also known as Oral Allergy Syndrome, is a

A recent trial by DBV Technologies has produced promising results for very young children with peanut allergies and their families. The trial assessed whether Viaskin Peanut – an immunotherapy skin patch – was safe, and if it worked for children

New research investigating the emotional impact of living with a peanut allergy has empathised the importance of exploring potential treatments. The study entitled Exploring Health-Related Quality of Life Burden in Peanut Allergy and the Potential Benefit of Oral Immunotherapy: Estimation